Literature DB >> 27343038

B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?

Ilja Striz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27343038     DOI： 10.1007/s10620-016-4231-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

Review 1.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 2.  Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser.

Authors:  Morton A Scheinberg; Colin M Hislop; Renee S Martin
Journal:  Expert Opin Biol Ther       Date:  2016       Impact factor: 4.388

3.  B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.

Authors:  Peipei Zhang; Xiaojing Liu; Aili Guo; Jing Xiong; Yu Fu; Kaifang Zou
Journal:  Dig Dis Sci       Date:  2016-04-07       Impact factor: 3.199

Review 4.  Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations.

Authors:  Namrata Singh; Bharat Kumar; Vijay Aluri; Petar Lenert
Journal:  J Allergy Clin Immunol       Date:  2016-03-04       Impact factor: 10.793

5.  A role for BLyS in the activation of innate immune cells.

Authors:  Sook Kyung Chang; Bonnie K Arendt; Jaime R Darce; Xiaosheng Wu; Diane F Jelinek
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

6.  B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Authors:  Francesca Polverino; Borja G Cosio; Jaime Pons; Maria Laucho-Contreras; Paula Tejera; Amanda Iglesias; Angel Rios; Andreas Jahn; Jaume Sauleda; Miguel Divo; Victor Pinto-Plata; Lynette Sholl; Ivan O Rosas; Alvar Agustí; Bartolome R Celli; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 7.  Regulatory immune cells in regulation of intestinal inflammatory response to microbiota.

Authors:  M Sun; C He; Y Cong; Z Liu
Journal:  Mucosal Immunol       Date:  2015-06-17       Impact factor: 7.313

Review 8.  Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.

Authors:  Jason Orlando Dimitri Musci; Jack Stephen Cornish; Jan Däbritz
Journal:  J Gastroenterol       Date:  2016-03-14       Impact factor: 7.527

Review 9.  The role of macrophages and dendritic cells in the initiation of inflammation in IBD.

Authors:  Erin C Steinbach; Scott E Plevy
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325
  9 in total
  2 in total

1.  Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.

Authors:  Yu Fu; Lingli Wang; Cheng Xie; Kaifang Zou; Lei Tu; Wei Yan; Xiaohua Hou
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

Review 2.  Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.

Authors:  Marko Kumric; Piero Marin Zivkovic; Tina Ticinovic Kurir; Josip Vrdoljak; Marino Vilovic; Dinko Martinovic; Andre Bratanic; Ivan Kresimir Lizatovic; Josko Bozic
Journal:  Diagnostics (Basel)       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.